A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults
Clinical trial NCT02337855 · COMPLETED
Trial details
- NCT number
- NCT02337855
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-04
- Primary completion
- 2017-01-27
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.